-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$423.2023.47% Upside
Medpace Holdings, Inc. Frequently Asked Questions
-
What analysts cover Medpace Holdings, Inc.?
Medpace Holdings, Inc. has been rated by research analysts at Jefferies, Truist Financial, Robert W. Baird, Mizuho Securities, UBS in the past 90 days.